Key Sessions
Claudia Höbartner, Ph.D.
New Concepts in Nucleic Acid Chemistry Innovation and Applications for Therapeutics Development
University of Würzburg
Sergey Tsukanov, PhD
Making Oligonucleotides a High-Volume Reality: Next-Gen Platforms and Strategy for Oligonucleotide Manufacturing
Eli Lilly and Company
Jacob Challand Kofoed, PhD
Next Generation GLP-1 Therapeutics
Novo Nordisk A/S
Michael Kopach, PhD
Case Study of a Novel Incretin Triagonist for Obesity and Type 2 Diabetes Treatment
Eli Lilly and Company
Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm) - Europe/Amsterdam
Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm) - Europe/Amsterdam
08:30 - 09:0030 mins
Registration and Coffee
Optional Pre-Conference Morning Workshops: 9.00am-12.00pm
09:00 - 12:00180 mins
Workshop #1:CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact
CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact
- Thomas Rupp - Vice President, CMC Strategy, Axolabs Berlin GmbH
- Sonja Merkas, PhD - Founder and CEO, Livinovea
09:00 - 12:00180 mins
Workshop #2:Oligonucleotide CMC Across the Product Lifecycle: From Preclinical to Market
Workshop #2: Oligonucleotide CMC Across the Product Lifecycle: From Preclinical to Market
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
09:00 - 09:1010 mins
Workshop #3:Innovations and Challenges in Peptide Manufacturing and Purification
Moderator’s Welcome and Opening Remarks
- Bruce Morimoto, PhD - Independent Consultant, TIDES Advisor
09:10 - 09:4535 mins
Workshop #3:Innovations and Challenges in Peptide Manufacturing and Purification
Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies
- Robert Hagopian - Global Director, Biotech Partnerships, PolyPeptide Group
- El Djouhar Rekaï, PhD - Process & Analytical Development Director at PolyPeptide Group, PolyPeptide Group
09:45 - 10:2035 mins
Workshop #3:Innovations and Challenges in Peptide Manufacturing and Purification
A Symmetrical Alternative to Lysine-core Based Branched Peptides
- Beatriz De La Torre, Ph.D. - Research Professor, Laboratory of Medicine and Med, University Of KwaZulu-Natal
10:20 - 10:5030 mins
Workshop #3:Innovations and Challenges in Peptide Manufacturing and Purification
Networking Refreshment Break
10:50 - 11:2535 mins
Workshop #3:Innovations and Challenges in Peptide Manufacturing and Purification
Individualised Cancer Vaccines: Developing a High-throughput cGMP Peptide Manufacturing Philosophy
- Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
11:25 - 12:0035 mins
Workshop #3:Innovations and Challenges in Peptide Manufacturing and Purification
Innovations in Preparative Purification of Synthetic Peptides
- Marc Jacob, PhD - Head of Strategic Development, Chromatography Products, YMC America
- Thomas Müller-Späth, PhD - CEO, ChromaCon AG
Luncheon Spotlight Presentations (for Morning Workshop Attendees Only)
12:00 - 12:1515 mins
Workshop Luncheon Spotlight Presentation 1
Transition to Lunch Spotlight Presentation
12:00 - 12:1515 mins
Workshop Luncheon Spotlight Presentation 2
Transition to Lunch Spotlight Presentation
12:15 - 12:4530 mins
Workshop Luncheon Spotlight Presentation 1
Innovating Oligonucleotide Production: Enzymatic Fragment Ligation for siRNA
- Wuming Yan - Chief Scientist Oligonucleotides, Asymchem
12:45 - 13:1025 mins
Workshop Luncheon Spotlight Presentation 1
Short Break and Transition to Keynote Session
12:45 - 13:1025 mins
Workshop Luncheon Spotlight Presentation 2
Short Break and Transition to Keynote Sessions
13:10 - 13:155 mins
Keynote Sessions - MAIN CONFERENCE
Chairperson’s Remarks
13:15 - 13:5035 mins
Keynote Sessions - MAIN CONFERENCE
Making Oligonucleotides a High-Volume Reality: Next-Gen Platforms and Strategy for Oligonucleotide Manufacturing
- Sergey Tsukanov, PhD - Senior Director Chemistry, Eli Lilly and Company
13:50 - 14:2535 mins
Keynote Sessions - MAIN CONFERENCE
Next Generation GLP-1 Therapeutics
- Jacob Challand Kofoed, PhD - Senior Principal Scientist, Peptide Research, Novo Nordisk A/S
14:25 - 15:0035 mins
Keynote Sessions - MAIN CONFERENCE
Case Study of a Novel Incretin Triagonist for Obesity and Type 2 Diabetes Treatment
- Michael Kopach, PhD - Associate Vice President, Synthetic Molecule Design and Development, Eli Lilly and Company
15:00 - 15:5050 mins
Keynote Sessions - MAIN CONFERENCE
Networking Refreshment Break and Grand Opening of Poster and Exhibit Hall
15:50 - 16:2535 mins
Keynote Sessions - MAIN CONFERENCE
New Concepts in Nucleic Acid Chemistry Innovation and Applications for Therapeutics Development
- Claudia Höbartner, Ph.D. - Professor of Organic Chemistry, University of Würzburg
16:25 - 17:0035 mins
Keynote Sessions - MAIN CONFERENCE
Late Breaking Keynote
17:00 - 18:3090 mins
Keynote Sessions - MAIN CONFERENCE
Networking Reception in Poster and Exhibit Hall
18:30 - 18:355 mins
Keynote Sessions - MAIN CONFERENCE
Close of Day One
* 活动内容有可能不事先告知作更动及调整。